Company or ticker...

Denali Therapeutics

Denali develops medicines for neurodegenerative and lysosomal storage diseases.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

DNLI

4.1B

0.0

n/a

53.48%

Key Facts

M. Cap

PS

PE

YTD

4.1B

0.0

n/a

53.48%

10MA

20MA

50MA

200MA

$DNLI